A randomised phase 2 study comparing different dose approaches of induction treatment of regorafenib in previously treated metastatic colorectal cancer patients (REARRANGE trial)

by | Jan 1, 2022 | Publicaciones - B-05 | 0 comments

Argiles, G; Mulet, N; Valladares-Ayerbes, M; Vieitez, JM; Gravalos, C; Garcia-Alfonso, P; Santos, C; Tobena, M; Garcia-Paredes, B; Benavides, M; Cano, MT; Loupakis, F; Rodriguez-Garrote, M; Rivera, F; Goldberg, RM; Cremolini, C; Bennouna, J; Ciardiello, F; Tabernero, JM; Aranda, E; Tabernero, J – 2022